Wolterman Dan
SEC CIK 1586330 · EDGAR
Most active insiders at GMED, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | ZARRILLI STEPHEN T | Dir | — | $4.28M |
| 2 | Davidar David D | Dir | — | $4.17M |
| 3 | Huller Kelly | SVP, GC, Corp. Sec | — | $3.44M |
| 4 | TOBIN JAMES R | Dir | — | $2.24M |
| 5 | Kline Kyle | SVP, CFO | — | $2.03M |
| 6 | RHOADS ANN D | Dir | — | $818.0K |
| 7 | Norwalk Leslie V | Dir | — | $557.6K |
| 8 | Paul David C | Executive COB, Dir, 10% | — | — |
Wolterman Dan made no open-market trades at GMED in the last 12 months.
Transactions 3
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-09-06 | 2023-09-01 | GMED | GLOBUS MEDICAL INC | Wolterman Dan | Dir | A - Grant | — | +24.0K | 24.0K | New | — |
| A | 2022-01-10 | 2021-12-23 | HYPR | Hyperfine, Inc. | Wolterman Dan | Dir | A - Grant | $0.00 | +19.6K | 19.6K | New | $0 |
| 2021-12-23 | 2021-12-23 | HYPR | Hyperfine, Inc. | Wolterman Dan | Dir | A - Grant | $0.00 | +16.5K | 16.5K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations